Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.88B
Close$
$-4.38
134.7% downside
Current Fair Value
134.7% downsideOvervalued by 134.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.88 Billion |
|---|---|
| Enterprise Value | $7.35 Billion |
| Dividend Yield | $0.11 (0.89%) |
| Earnings per Share | $0.56 |
| Beta | 0.3 |
| Outstanding Shares | 544,819,911 |
Return
| Return on Equity | 6.67% |
|---|---|
| Return on Assets | 4.02% |
| Return on Invested Capital | 6.36% |
Valuation & Multiples
| P/E Ratio | 28.99 |
|---|---|
| PEG | -57.25 |
| Price to Sales | 6.32 |
| Price to Book Ratio | 2.11 |
| Enterprise Value to Revenue | 5.78 |
| Enterprise Value to EBIT | 24.1 |
| Enterprise Value to Net Income | 30 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$277.61 M
Average shareholder expectationNext Earnings Call
Expected Date
March 31, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Garden Biopharmaceutical Co.,Ltd.
1,163 employees
CEO: Huan Zheng Ma Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical ...